Date：21 July (Wednesday) 14:00 – 15:30 (GMT+8)
Venue：www.bioasiataiwan.com / Online event platform
Financing is the fuel that drives growth in the biomedical sector, and for investors seeking successful exits in this sector, picking the right strategy makes all the difference. IPO is still a popular option, but is joined today by creative M&A and early-stage financing deals. Join session organizers PwC and a panel of VC, finance and expert pharma deal makers they illuminate the full spectrum of investment and exit options while spotlighting recent significant biotech IPOs, mergers, acquisitions and licensing deals.